Related Experiment Video
Updated: Jun 17, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Folate Receptors' Expression in Gliomas May Possess Potential Nanoparticle-Based Drug Delivery Opportunities
Eva McCord1,2, Shreya Pawar1,3, Tejaswi Koneru1,4
1Use-inspired Biomaterials & Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, United States.
Abstract:
Brain cancer effected around estimated 23 890 adults and 3540 children under the age of 15 in 2020. The chemotherapeutic agents that are already approved by the FDA for brain cancer are proving to be not highly effective because of the interference from the tumor microenvironment as well as their own toxicities. Added to this is the impedance presented by the extremely restrictive permeability of the blood brain barrier (BBB). Targeted nanoparticulate drug delivery systems offer a good opportunity to traverse the BBB and selectively target the tumor cells. Folate receptors are found to be one of the most useful targets for drug delivery to the brain. Hence, this Mini-Review discusses the folate receptors and their application in the treatment of brain cancers using targeted nanoparticles.
Insights
Targeted nanoparticles offer a promising approach to overcome the blood-brain barrier (BBB) and treat brain cancers. Folate receptors are key targets for delivering chemotherapy drugs effectively to brain tumors.
Area of Science:
- Neuro-oncology
- Nanomedicine
- Drug Delivery Systems
Background:
- Brain cancer affects thousands of adults and children annually.
- Current FDA-approved chemotherapies for brain cancer have limited efficacy due to the tumor microenvironment and toxicity.
- The blood-brain barrier (BBB) significantly impedes drug delivery to brain tumors.
Purpose of the Study:
- To review the application of folate receptors in targeted nanoparticle drug delivery for brain cancer treatment.
- To explore strategies for overcoming the BBB using nanotechnology.
Main Methods:
- Review of existing literature on folate receptors and nanoparticle drug delivery.
- Analysis of the role of the tumor microenvironment and BBB in treatment efficacy.
- Discussion of targeted delivery systems utilizing folate receptors.
Main Results:
- Folate receptors are identified as highly useful targets for brain drug delivery.
- Targeted nanoparticulate systems show potential for traversing the BBB.
- Selective targeting of tumor cells by nanoparticles can enhance treatment outcomes.
Conclusions:
- Targeted nanoparticles offer a viable strategy to improve brain cancer treatment by overcoming BBB limitations.
- Folate receptor-targeted nanodrug delivery systems represent a promising therapeutic avenue for brain malignancies.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Related Concept Videos
Higher Mental Functions of the Brain: Language
Language formation and comprehension take place in the dominant hemisphere. The dominant hemisphere is responsible for understanding the meaning of spoken, written, or sign language, as well as the ability to communicate. For most people, the left hemisphere is the dominant one. The right hemisphere, then, gives tone and emotional context to the...
Cerebral Hemispheres
Lateralization
Language and Cognition
Learning Disabilities
Dyslexia
Dyslexia is a...